Ubs Group Ag Xoma Corp Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Xoma Corp stock. As of the latest transaction made, Ubs Group Ag holds 4,151 shares of XOMA stock, worth $134,367. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,151

Previous 16,110 74.23%

Holding current value

$134,367

Previous $405,000 61.98%

% of portfolio

0.0%

Previous 0.0%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$24.77 - $38.27 $296,224 - $457,670	-11,959 Reduced 74.23%	4,151 $154,000
Q2 2025 Aug 14, 2025	BUY	$18.76 - $27.49 $211,556 - $310,004	11,277 Added 233.33%	16,110 $405,000
Q1 2025 May 13, 2025	SELL	$19.93 - $28.12 $37,807 - $53,343	-1,897 Reduced 28.19%	4,833 $96,000
Q4 2024 Feb 14, 2025	BUY	$25.11 - $33.88 $72,718 - $98,116	2,896 Added 75.53%	6,730 $176,000
Q3 2024 Nov 14, 2024	BUY	$23.1 - $29.85 $32,201 - $41,610	1,394 Added 57.13%	3,834 $101,000

Q2 2024 Aug 13, 2024	SELL	$22.31 - $26.7 $109,653 - $131,230	-4,915 Reduced 66.83%	2,440 $57,000
Q1 2024 May 13, 2024	SELL	$19.1 - $26.32 $11,269 - $15,528	-590 Reduced 7.43%	7,355 $176,000
Q4 2023 Feb 09, 2024	BUY	$13.82 - $19.13 $54,865 - $75,946	3,970 Added 99.87%	7,945 $146,000
Q3 2023 Nov 09, 2023	SELL	$14.02 - $17.71 $2,411 - $3,046	-172 Reduced 4.15%	3,975 $56,000
Q2 2023 Aug 11, 2023	BUY	$17.0 - $21.58 $54,876 - $69,660	3,228 Added 351.25%	4,147 $78,000
Q1 2023 May 12, 2023	SELL	$18.01 - $23.12 $4,448 - $5,710	-247 Reduced 21.18%	919 $19,000
Q4 2022 Feb 08, 2023	SELL	$16.0 - $25.45 $5,456 - $8,678	-341 Reduced 22.63%	1,166 $21,000
Q3 2022 Nov 10, 2022	BUY	$15.9 - $29.56 $23,706 - $44,073	1,491 Added 9318.75%	1,507 $27,000
Q2 2022 Aug 10, 2022	SELL	$17.05 - $28.22 $61,652 - $102,043	-3,616 Reduced 99.56%	16 $0
Q1 2022 May 16, 2022	BUY	$19.62 - $29.61 $13,557 - $20,460	691 Added 23.5%	3,632 $101,000
Q4 2021 Feb 14, 2022	BUY	$20.04 - $27.57 $58,617 - $80,642	2,925 Added 18281.25%	2,941 $61,000
Q2 2021 Aug 13, 2021	SELL	$29.0 - $40.64 $36,743 - $51,490	-1,267 Reduced 98.75%	16 $1,000
Q1 2021 May 12, 2021	SELL	$33.21 - $43.99 $15,974 - $21,159	-481 Reduced 27.27%	1,283 $52,000
Q4 2020 Feb 11, 2021	BUY	$19.26 - $45.61 $24,306 - $57,559	1,262 Added 251.39%	1,764 $78,000
Q3 2020 Nov 12, 2020	SELL	$16.25 - $20.94 $27,478 - $35,409	-1,691 Reduced 77.11%	502 $9,000
Q2 2020 Jul 31, 2020	BUY	$18.45 - $25.51 $40,460 - $55,943	2,193 New	2,193 $43,000
Q1 2020 May 01, 2020	SELL	$15.11 - $28.71 $11,952 - $22,709	-791 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$17.5 - $28.66 $7,927 - $12,982	-453 Reduced 36.41%	791 $22,000
Q3 2019 Nov 14, 2019	SELL	$15.02 - $21.51 $41,305 - $59,152	-2,750 Reduced 68.85%	1,244 $25,000
Q2 2019 Aug 14, 2019	BUY	$11.83 - $18.98 $3,134 - $5,029	265 Added 7.11%	3,994 $60,000
Q1 2019 May 14, 2019	SELL	$11.95 - $15.53 $5,461 - $7,097	-457 Reduced 10.92%	3,729 $46,000
Q4 2018 Feb 14, 2019	BUY	$11.27 - $17.54 $6,931 - $10,787	615 Added 17.22%	4,186 $53,000
Q3 2018 Nov 14, 2018	SELL	$15.67 - $25.73 $1,739 - $2,856	-111 Reduced 3.01%	3,571 $63,000
Q2 2018 Aug 14, 2018	BUY	$19.68 - $25.28 $40,698 - $52,279	2,068 Added 128.13%	3,682 $77,000
Q1 2018 May 15, 2018	SELL	$19.86 - $35.92 $1,926 - $3,484	-97 Reduced 5.67%	1,614 $33,000
Q4 2017 Feb 14, 2018	BUY	$19.71 - $36.79 $3,981 - $7,431	202 Added 13.39%	1,711 $61,000
Q3 2017 Nov 14, 2017	BUY	$7.31 - $20.8 $3,128 - $8,902	428 Added 39.59%	1,509 $30,000
Q2 2017 Aug 14, 2017	SELL	N/A	-1,011 Reduced 48.33%	1,081 $8,000
Q1 2017 Nov 14, 2017	BUY	N/A	2,092	2,092 $15,000

Others Institutions Holding XOMA

# of Institutions

Shares Held

7.13M

Call Options Held

Put Options Held

View Full List

About XOMA Corp

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $371M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

More about XOMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account